KCNH8: A Potassium Channel Subfamily H Member 8 Drug Target and Biomarker

Target Name: KCNH8

NCBI ID: G131096

KCNH8

KCNH8: A Potassium Channel Subfamily H Member 8 Drug Target and Biomarker

Introduction

Potassium (K+) is one of the most crucial ion channels in the human body, responsible for maintaining the resting membrane potential of various tissues and organs. The voltage-gated potassium channels, also known as H channels, are a subfamily of the potassium channel that play a pivotal role in neural and cardiorespiratory function. In this article, we will explore the potassium channel subfamily H member 8 (KCNH8), a potential drug target (or biomarker), and discuss its role in neural and cardiorespiratory functions. Function in cardiomyocytes.

Function and structure of KCNH8

KCNH8 is a coding gene belonging to potassium channel subfamily H member 8. This family includes 12 members, most of which encode genes that produce voltage-dependent potassium channels. KCNH8 is clearly localized on the cell membrane and is an ideal gene for studying potassium ion permeability.

KCNH8 is a transmembrane protein that forms two major alleles on the cell membrane. One is the N-terminal gene and the other is the C-terminal gene. The N-terminal gene produces a voltage-dependent potassium channel, while the C-terminal gene encodes a protein with a higher affinity potassium channel.

Biological functions of KCNH8

KCNH8 plays multiple biological functions in nerve and cardiomyocytes. In nerve cells, KCNH8 is mainly involved in the excitatory transmission process of neurons. The initiation and maintenance of action potentials depends on the opening and closing of voltage-dependent potassium channels. The activation and inactivation states of KCNH8 are closely related to the normal function of neurons.

In cardiomyocytes, KCNH8 plays an important role in cardiac contraction and relaxation. The contraction and relaxation of cardiomyocytes are achieved through the influx of potassium ions. The activation and inactivation states of KCNH8 are closely related to the contraction and relaxation processes of cardiomyocytes.

Pharmacological significance of KCNH8

KCNH8 has high prospects in the field of drug research and development. Because of KCNH8's function in nerve and cardiomyocytes, researchers have intensively studied it as a drug target. Currently, some drugs, such as nicotine, quinidine, and verapamil, have been shown to modulate the function of KCNH8, thereby affecting nerves and cardiomyocytes.

In addition, some studies have also shown that by regulating the function of KCNH8, the physiological and pathological processes of nerves and cardiomyocytes can be improved, such as synaptic plasticity of neurons, contraction and relaxation functions of cardiomyocytes, etc.

Biological significance and clinical applications of KCNH8

The biological functions of KCNH8 in nerve and cardiomyocytes make it an important target in the field of drug development. With the continuous development of science and technology, researchers' understanding of KCNH8 is also increasing. As the research on the function of KCNH8 continues to deepen, it is expected that more pharmacologically active compounds will be developed in the future for the treatment of neurological and cardiac diseases.

At the same time, as a biomarker, KCNH8 also has broad application prospects in disease diagnosis and prognosis. For example, by detecting the expression level of the KCNH8 gene, the degree of neuronal damage can be predicted and provide guidance for the treatment of neuronal diseases. In addition, KCNH8 can also be used as a biomarker for the assessment of myocardial lesions, providing an important basis for the diagnosis and prognosis of myocardial diseases.

in conclusion

KCNH8 is a potential drug target (or biomarker) that exerts multiple biological functions in nerve and cardiomyocytes. Through in-depth study of the biological functions and pharmacological significance of KCNH8, it is expected to develop more pharmacologically active compounds for the treatment of neurological and cardiac diseases. At the same time, as a biomarker, KCNH8 also has broad application prospects in disease diagnosis and prognosis.

Protein Name: Potassium Voltage-gated Channel Subfamily H Member 8

Functions: Pore-forming (alpha) subunit of voltage-gated potassium channel. Elicits a slowly activating, outward rectifying current. Channel properties may be modulated by cAMP and subunit assembly

The "KCNH8 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KCNH8 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets